EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY-NC-ND 4.0

Empowerment and quality of life in gynecological cancer survivors: Outcomes from a multicenter quasi‐experimental cohort study from Norway (the LETSGO trial)

Ingvild Vistad iD, Mette Skorstad, Sveinung Berntsen, Ingrid Demmelmaier, Line Bjørge, Lonneke V van de Poll-Franse, Kristina Lindemann iD, Elisabeth Berge Nilsen, Ala Haug, Anne Gry Bentzen, Tonje Bohlin, Trine Stokstad und 5 weitere

Cancer · 2025

DOI: 10.1002/cncr.70040 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer, 2025. Verfasst von Ingvild Vistad und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Sorlandet Hospital Trust Kristiansand, Kristiansand, Norway. Hauptthemen laut MEDLINE: Quality of Life, Genital Neoplasms, Female, Cancer Survivors, Empowerment. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Stiftelsen Uni, Helse Sør-Øst RHF, Kreftforeningen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Increasing outpatient demands and unmet patient needs necessitate personalized follow‐up care for cancer survivors. This study investigated whether a self‐management–focused follow‐up model improves empowerment and quality of life (QoL) in gynecological cancer survivors compared to standard follow‐up.

Methods

Twelve Norwegian hospitals participated in this cohort study. Patients initiating routine follow‐up after primary treatment were eligible and allocated to either intervention or standard care follow‐up groups based on their treatment hospital. The intervention included nurse‐led consultations using coaching techniques for education on symptom monitoring and healthy lifestyle, alternated with physician‐led consultations and access to a mobile app. Standard follow‐up consisted of physician‐led consultations only. The primary outcome was change in patient empowerment over 12 months, measured with the self‐monitoring and insight domain of the Health Education Impact Questionnaire (heiQ). Secondary outcomes included changes in remaining heiQ domains and QoL. Data were analyzed according to intention‐to‐treat principles using linear mixed effects models.

Results

Among 741 participants (intervention: 378, standard: 363), baseline characteristics were comparable. At 12 months, no significant differences were observed in self‐monitoring and insight (Δ = 0.02 [95% confidence interval (CI), –0.04 to 0.08]; effect sizes [ES] = 0.29). However, health‐directed activity (Δ = 0.15 [95% CI, 0.04–0.25]; ES = 0.15), emotional well‐being (Δ = 0.12 [95% CI, 0.02–0.20]; ES = 0.15), social functioning (Δ = 5.2 [95% CI, 1.1–9.3]; ES = 0.41), and physical functioning (Δ = 2.5 [95% CI, 0.0–5.0]; ES = 0.20) were significantly more improved in the intervention group.

Conclusion

Lifestyle and Empowerment Techniques in Survivorship of Gynaecologic Oncology follow‐up did not significantly impact self‐monitoring and insight, but positively influenced other survivorship domains, indicating its potential for enhancing self‐management and QoL in gynecological cancer survivors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeGenital Neoplasms, FemaleCancer SurvivorsEmpowermentHumansFemaleNorwayMiddle AgedAgedAdultCohort StudiesSurveys and QuestionnairesSelf-Management

Stichwörter der Autor:innen

gynecological cancer survivorshipnurse‐led interventionpatient empowermentpersonalized follow‐up carequality of lifeself‐management

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Sorlandet Hospital Trust Kristiansand, Kristiansand, Norway.
  • Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Medical Department, Clinical Institute II, University of Bergen, Bergen, Norway.
  • Department of Sport Science and Physical Education, University of Agder, Kristiansand, Norway.
  • Department of Public Health and Caring Science, University of Uppsala, Uppsala, Sweden.
  • Department of Clinical Science, Centre for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway.

ORCID-Profile: Ingvild Vistad, Kristina Lindemann

Förderung

  • Stiftelsen Uni
  • Helse Sør-Øst RHF
  • Kreftforeningen

Zitieren

APA

Vistad, I., Skorstad, M., Berntsen, S., Demmelmaier, I., Bjørge, L., van de Poll-Franse, L. V., Lindemann, K., Nilsen, E. B., Haug, A., Bentzen, A. G., Bohlin, T., Stokstad, T., Brummer, T., Liavaag, A., Lomsdal, S., Holstad, A. D., & Hagen, M. C. (2025). Empowerment and quality of life in gynecological cancer survivors: Outcomes from a multicenter quasi‐experimental cohort study from Norway (the LETSGO trial). Cancer. https://doi.org/10.1002/cncr.70040

Vancouver

Vistad I, Skorstad M, Berntsen S, Demmelmaier I, Bjørge L, van de Poll-Franse LV, et al. Empowerment and quality of life in gynecological cancer survivors: Outcomes from a multicenter quasi‐experimental cohort study from Norway (the LETSGO trial). Cancer. 2025. doi:10.1002/cncr.70040

BibTeX
@article{Vistad2025,
  author = {Vistad, Ingvild and Skorstad, Mette and Berntsen, Sveinung and Demmelmaier, Ingrid and Bjørge, Line and van de Poll-Franse, Lonneke V and Lindemann, Kristina and Nilsen, Elisabeth Berge and Haug, Ala and Bentzen, Anne Gry and Bohlin, Tonje and Stokstad, Trine and Brummer, Tea and Liavaag, Astrid and Lomsdal, Sølvi and Holstad, Anja Døssland and Hagen, Milada C},
  title = {Empowerment and quality of life in gynecological cancer survivors: Outcomes from a multicenter quasi‐experimental cohort study from Norway (the LETSGO trial)},
  journal = {Cancer},
  year = {2025},
  doi = {10.1002/cncr.70040}
}
Kostenlos starten →